Traders and Investors Trend Analysis Reports: (NASDAQ: BGMD), (NASDAQ: SOMX)
New York, NY -- (SBWIRE) -- 12/11/2012 -- BG Medicine Inc. (NASDAQ: BGMD), a provider of drug research and development services, is seeing a huge rally in mid-day trading today after the company announced that obtained CE Mark for its CardioSCORE test in Europe. The company’s President and CEO, Eric Bouvier said that he believes the CardioSCORE test will be a pivotal and disruptive game-changer in the primary prevention of major cardiovascular events and treatment of disease, representing a major advancement over the diagnostic tools used by clinician for the past 15 years.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here